Page 6,996«..1020..6,9956,9966,9976,998..7,0107,020..»

Overlook Medical Center in Summit ranked No.1 hospital in New Jersey for stroke and neurological disorders

Posted: Published on March 16th, 2012

Overlook Medical Center Overlook ranked third overall among all hospitals in the state and therefore, ranked as the top hospital in Union County. Overlook was also ranked among the top three hospitals in New Jersey across several categories, including high-risk pregnancy, breast cancer, prostate cancer, hip and knee repair, and treatment of heart failure, among others by Castle Connolly Medical Ltd., one of the nations most respected health care research and information companies. These rankings are published in Inside Jersey magazines April 2012 issue. Atlantic Health Systems hospitals, which include Morristown, Overlook, and Newton Medical Centers, and Goryeb Childrens Hospital, placed in the top three in nearly every category ranked by Castle Connolly. Overlook was also ranked among the Top 3 hospitals across several categories, including overall quality, high-risk pregnancies, hip and knee repair, prostate and breast cancer treatment. This year Overlook made huge leaps up the list in high-risk pregnancy as well as pediatric and prostate cancer treatment! The rankings appear in Inside Jersey magazines April 2012 issue. We were also ranked among the Top 3 hospitals across several categories, including overall quality, high-risk pregnancies, hip and knee repair, prostate and breast cancer treatment. This year Overlook made huge … Continue reading →

Comments Off on Overlook Medical Center in Summit ranked No.1 hospital in New Jersey for stroke and neurological disorders

Military study aims to aid troops with mild TBI

Posted: Published on March 16th, 2012

A team of experts at San Antonio Military Medical Center has launched a military study aimed at improving outcomes for service members suffering from a signature wound of today's wars: traumatic brain injury. The Study of Cognitive Rehabilitation Effectiveness, dubbed the SCORE trial, is examining cognitive rehabilitation therapy's value as a treatment for service members with mild TBI. The Defense and Veterans Affairs departments teamed up on this study to determine the best treatment for combat troops who are experiencing mild TBI symptoms -- such as difficulties with attention, concentration, memory and judgment -- three to 24 months post-injury, explained Douglas B. Cooper, the study's lead and a clinical neuropsychologist for the center's Traumatic Brain Injury Service. We have a lot of great interventions to help in the first few days after concussion, he said in an interview with American Forces Press Service. We can pull them out, get them rest and get them better. However, We don't have as many good interventions later on six months, 12 months or two years post-injury, acknowledged Cooper, who also serves as the director of the Military Brain Injury Rehabilitation Research Consortium. The trial's aim is to determine if cognitive rehabilitation therapy improves … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Military study aims to aid troops with mild TBI

Kessler Foundation neuroscientist to speak at Brain Injury Awareness Day on Capitol Hill

Posted: Published on March 16th, 2012

Public release date: 16-Mar-2012 [ | E-mail | Share ] Contact: Carolann Murphy CMurphy@KesslerFoundation.org 973-324-8382 Kessler Foundation West Orange, NJ -- On Wednesday, March 21, the Congressional Brain Injury Task Force brings representatives from the brain injury community to Capitol Hill for Brain Injury Awareness (BIA) Day. The day starts with the BIA Fair, where attendees share information on policy issues, research, diagnosis and screening and care and rehabilitation. The afternoon features a briefing on "The Impact of Brain Injury: Any Time, Any One, Any Age." William A.B. Ditto, MSW, LSW, past president & chair of Public Policy, National Association of State Head Injury Administrators, will moderate the discussion, focusing on how federal policy can help improve services and promote research that improves rehabilitation and treatment outcomes. Task Force co-chairs Rep. Bill Pascrell (NJ-08 ) and Todd Russell Platts (PA-19) will preside over the panel of experts from the Centers for Disease Control, National Institutes of Health, Veterans Administration, National Association of States United for Aging & Disability, and Kessler Foundation. Panelist Jordan Grafman, PhD, is director of TBI Research at Kessler Foundation. Dr. Grafman's investigation of brain function and behavior contributes to advances in medicine, rehabilitation, and psychology, and … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Kessler Foundation neuroscientist to speak at Brain Injury Awareness Day on Capitol Hill

MS walk planned for April 21 in Midland

Posted: Published on March 16th, 2012

The Michigan Chapter of the National Multiple Sclerosis Society and those living with MS in Michigan have been working to build awareness about multiple sclerosis this week during Multiple Sclerosis Awareness Week. The organization also is promoting a Walk MS event planned for 10 a.m. April 21 at Central Middle School. People can visit http://www.walkMSmi.org to find out more about the three mile walk. Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system which interrupts the flow of information within the brain, and between the brain and body. Symptoms range from reduced or lost mobility to numbness and tingling to blindness and paralysis. Other symptoms include cognitive difficulty, fatigue and weakness. The progress, severity and specific symptoms of MS cannot be predicted. Most people are diagnosed between the ages of 20 and 50, with at least two to three times more women than men having the disease. MS affects more than 18,000 individuals in Michigan, 400,000 people in the U.S., and more than 2 million worldwide. "Advances in research are moving us closer to stopping the disease, restoring function and ending MS forever," a spokesperson said. "MS has moved from an untreatable disease in 1993 to … Continue reading →

Posted in MS Treatment | Comments Off on MS walk planned for April 21 in Midland

Regenx® Medical Institute Expanding to Provide Better Hormone Replacement Therapy that can Protect Against Cancer

Posted: Published on March 16th, 2012

Regenx Medical Institute, a leading provider of customized Hormone Replacement Therapy (HRT) programs, is reacting to new studies on the benefits of HRT for men and women and the importance of medically supervised therapies versus self-medications. Bay Harbor, Miami, FL (PRWEB) March 16, 2012 A new landmark study from March 2012 has shown that certain estrogen replacement therapies after menopause protects against breast cancer even long after treatment is stopped. These therapies are design to fight the very common symptoms of female hormone imbalance such as hot flashes, vaginal dryness, lower sex drive and a general feeling of fatigue. The study came from the Women's Health Initiative (WHI), a large US study of post-menopausal women launched in 1993. The results showed that women who had estrogen HRT for seven years were 20 percent less likely to develop breast cancer compared to a control group that only received placebo treatment. This positive effect also lasted for more than five years after the therapy ended. Doctors emphasized that the benefit had to be balanced against stroke and blood clot risks that resulted from Hormone Replacement Therapy. They recommended taking hormones at the lowest dose possible and balancing the medication with regards to … Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on Regenx® Medical Institute Expanding to Provide Better Hormone Replacement Therapy that can Protect Against Cancer

Controversial scientist plans to clone a mammoth

Posted: Published on March 16th, 2012

South Korean Hwang Woo Suk was long regarded as a cloning pioneer - until he was charged with having faked much of his stem cell research. Now, he is back with a new project: he wants to clone a woolly mammoth. South Korean researcher and cloning pioneer Hwang Woo Suk hasn't been in the scientific spotlight ever since he claimed to have successfully created human embryonic stem cells by cloning six years ago, and that research turned out to be fake. Now, the controversial veterinarian and researcher is in the headlines again. He wants to use frozen tissue samples to recreate an animal that last walked the earth some 10,000 years ago: a woolly mammoth. Hwang Woo Su successfully cloned Snuppy in 2005 The scientist recently signed an accord to that effect with a university in Russia's Sakha Republic. Vast areas of the republic are covered in permafrost that has begun to thaw over the years due to climate change, uncovering the well-preserved remains of several mammoths that had lain frozen in the ice for more than 10.000 years. To clone new life from the remains, Hwang needs an intact cell nucleus that he hopes could contain the animal's entire … Continue reading →

Posted in Stem Cell Research | Comments Off on Controversial scientist plans to clone a mammoth

Personalized Medicine, UnitedHealth Group – Video

Posted: Published on March 16th, 2012

15-03-2012 12:52 Personalized Medicine: trends and prospects for the new science of genetic testing and molecular diagnostics Overview of new working paper -- Mapping the Future of Genetic Testing and Molecular Diagnostics: A payer's perspective on integrating personalized care into clinical practice Review of results of survey of consumers and physicians about genetic testing Deneen Vojta, UnitedHealth Group Read more: Personalized Medicine, UnitedHealth Group - Video … Continue reading →

Comments Off on Personalized Medicine, UnitedHealth Group – Video

Integrating new genetic testing technologies into clinical pathways – Video

Posted: Published on March 16th, 2012

15-03-2012 14:59 What is the relationship between implementation guidelines and reimbursement? Are payers the ultimate gatekeeper? Is it worth educating healthcare providers and patients? • Appropriate uses of genetic testing • Evidence-based guidelines and flexibility • Clinical management of new technology • Best practices (eg, breast cancer) Moderator: Robert Green, Harvard Medical School Robert McCormack, Veridex/J&J Thomas Musci, Novartis Diagnostics Greg Feero, Maine - Dartmouth Family Medicine Residency and NHGRI Deborah Heine, Claire Altman Heine Foundation The rest is here: Integrating new genetic testing technologies into clinical pathways - Video … Continue reading →

Comments Off on Integrating new genetic testing technologies into clinical pathways – Video

Evidence – Video

Posted: Published on March 16th, 2012

15-03-2012 16:33 This panel will consider the context for evidence, rather than the level of evidence, needed to move innovative technology into a clinical setting and how we will generate the needed evidence. Which evidence questions must be answered pre- market and which, if any, can be answered post-market? It will consider the often mismatched evidence requirements of patients, clinicians, test developers, regulators and payers. Collectively, we should define a burden of evidence that's appropriate for the balances of risk and speed that is appropriate in this space. This will require community-wide cooperation to collect and analyze data residing in many different places -- inside pharmaceutical companies, inside diagnostics companies and payers -- to measure outcomes and define the best use of diagnostics, and innovative methodologies to generate evidence (both in process and results). Moderator: Adam Berger, Institute of Medicine Patricia Deverka, Center for Medical Technology Policy Stanley Lapidus, SynapDx Susan Friedman, Facing Our Risk of Cancer Empowered David Clifford, PatientsLikeMe Roger Klein, University of South Florida Medical School See the original post: Evidence - Video … Continue reading →

Comments Off on Evidence – Video

Leukemia Patients' Outcomes Predicted With Genetic Profiling

Posted: Published on March 16th, 2012

Editor's Choice Academic Journal Main Category: Lymphoma / Leukemia / Myeloma Also Included In: Cancer / Oncology;Genetics Article Date: 16 Mar 2012 - 9:00 PDT email to a friend printer friendly opinions Current Article Ratings: Ross Levine, M.D., lead author of the study, member of Memorial Sloan-Kettering's Human Oncology Pathogenesis Program, and a medical oncologist on the Leukemia Service at Memorial Sloan-Kettering, said: We also want to use existing therapies more intelligently. It helps a great deal to know which subset of patients will actually benefit from intensive therapies, such as a higher dose of chemotherapy or a bone marrow transplant." Currently, there are just a few known genetic biomarkers that clinicians rely on in order to predict outcome in individuals suffering with leukemia. Although these biomarkers provide helpful information for some patients with AML, for the majority it is hard to predict the chance for a cure. The researchers used a method that incorporated information from a set of genes. This allowed them to categorize almost two-thirds of patients into clearly defined prognostic groups. Dr. Levine, explained: "Our goal was not to ask whether a certain gene or two raised or lowered risk, but to determine whether a combination … Continue reading →

Comments Off on Leukemia Patients' Outcomes Predicted With Genetic Profiling

Page 6,996«..1020..6,9956,9966,9976,998..7,0107,020..»